Barclays maintains Overweight on Hinge Health, raises target to $97

0 min read | Published on 13 Jul 2026, 05:26 PM |Updated on 13 Jul 2026, 07:30 PM

Reviewed by

Radhika SScanX News Team

Key Highlights

Barclays analyst Saket Kalia maintained an Overweight rating on Hinge Health (NYSE: HNGE) and raised the price target to $97 from $70, reflecting increased confidence in the company's growth prospects.

*this image is generated using AI for illustrative purposes only.

Barclays analyst Saket Kalia has maintained an Overweight rating on Hinge Health (NYSE: HNGE) and raised the price target to $97 from $70. The revised target reflects increased confidence in the company's growth prospects and market position.

Rating and Price Action

The firm's decision to upgrade the price target underscores a positive outlook on Hinge Health's performance. The new target of $97 represents a significant increase from the previous $70, suggesting potential upside from current levels.

Metric	Value
Rating	Overweight
Previous Price Target	$70
New Price Target	$97

The Overweight rating indicates that the analyst expects the stock to outperform the broader market or its sector peers in the near term.

Disclaimer: This article is AI-generated using data from ViewTrade. ScanX is not liable for any inaccuracies.

What specific growth drivers or market trends are fueling the increased confidence in Hinge Health's prospects?

How might competitors respond to Hinge Health's strengthened market position, and could this impact its growth trajectory?

What are the potential risks or challenges Hinge Health could face in achieving the revised $97 price target?

Hinge Health to report Q2 2026 results on August 4

0 min read | Published on 07 Jul 2026, 04:20 AM |Updated on 07 Jul 2026, 04:20 AM

Reviewed by

Naman SScanX News Team

Add as a preferred
source on Google

Key Highlights

Hinge Health, Inc. will announce its Q2 2026 financial results on August 4, 2026, followed by an earnings call. The company focuses on scaling healthcare delivery through AI and wearable technology.

*this image is generated using AI for illustrative purposes only.

Hinge Health, Inc. will report its financial results for the quarter ended June 30, 2026, after the U.S. financial markets close on Tuesday, August 4, 2026. The announcement will provide insight into the company's performance for the second quarter of the fiscal year.

Earnings Conference Call Details

Hinge Health will host an earnings conference call to discuss its results and guidance at 1:30 p.m. Pacific Time (4:30 p.m. Eastern Time) on the same day. The live audio webcast will be accessible on the Hinge Health Investor Relations website at ir.hingehealth.com. A replay of the webcast will be available on the same website shortly after the call concludes.

About Hinge Health

Hinge Health’s vision is to scale and automate the delivery of health care. Leveraging an AI-powered care model, wearable devices, and access to expert clinicians, Hinge Health delivers personalized, evidence-based care that improves member outcomes and experiences while reducing costs for clients. The company is headquartered in San Francisco, California.

Disclaimer: This article is AI-generated using data from ViewTrade. ScanX is not liable for any inaccuracies.

What guidance will Hinge Health provide for the remainder of the fiscal year?

How will the company's AI-powered care model impact its profitability in the coming quarters?

What strategic partnerships or expansions might Hinge Health pursue to scale its operations?